ODS/CHPA First Annual Bibliography Features Top 1999 Research
This article was originally published in The Tan Sheet
Executive Summary
A joint publication of the NIH Office of Dietary Supplements and the Consumer Healthcare Products Association features research evaluated against 12 criteria by an expert scientific panel.
You may also be interested in...
Antioxidant supplementation and diabetes
Antioxidant vitamins substantially decrease the susceptibility to oxidation of low-density lipoproteins in diabetic men, James Anderson, MD, et al., University of Kentucky, report in the October issue of the Journal of the American College of Nutrition. Researchers say their data suggest antioxidant supplements may lower the risk for artherosclerotic cardiovascular disease in diabetics, who face a significantly higher risk for than non-diabetics. Twenty diabetics received eight weeks of placebo, 12 weeks of daily antioxidant supplementation consisting of beta carotene (24 mg), ascorbate (1,000 mg) and alpha-tocopherol (800 IU), and another eight weeks of placebo. The study was supported in part by Roche Vitamins and HCF Nutritional Foundation
Calcium Linked To "Moderate" Reduction In Colorectal Adenoma Risk
"Calcium supplementation is associated with a significant - though moderate - reduction in the risk of recurrent colorectal adenomas," J.A. Baron, MD, Dartmouth-Hitchcock Medical Center, Lebanon, N.H., et al., conclude in a study published in the Jan. 14 New England Journal of Medicine. The four-year, six-center Calcium Polyp Prevention Study is partially supported by grants from the National Institutes of Health.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC